Skip to main content

Table 1 Patient characteristics and demographics

From: A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors

Characteristics

Median (range), mean ± SD or n (%)

Sex

 Males

22 (53.7%)

 Females

19 (46.3%)

Age (years)

58 (22–79)

Body weight (kg)

76 (53–120)

Height (cm)

174 (155–196)

Renal function (eGFR; mL/min/1.73m2)

77.5 (61.0–122)

Scan time after injection (min)

47 (35–78)

Administered peptide amount (µg)

12.3 (8.05–16.9)

Administered radioactivity (MBq)

92.7 (43.4–130)

SUVmax

 Aorta

1.59 ± 0.45

 Spleen

21.0 ± 4.50

 Liver

8.52 ± 2.11

 Thyroid

4.42 ± 1.53

SUVpeak

 Aorta

1.17 ± 0.36

 Spleen

19.0 ± 4.19

 Liver

7.16 ± 1.58

 Thyroid

3.20 ± 1.24

  1. SUV: standardized uptake value